Epic Research

Monday, April 28, 2014

Epic Research Update : Jubilant Life Science

Epic Update Jubilant Life SciencesJubilant Life Sciences, an integrated Pharmaceuticals and Life Sciences Company has received Abbreviated New Drug Application (ANDA) approval from the US Food and Drug Administration (USFDA) for Spironolactone Tablets, 25 mg, 50 mg and 100 mg, the generic version of Aldactone (of GD Searle), which is used as a diuretic to treat fluid retention (edema) caused by congestive heart failure and cirrhosis of the liver.

For more information ✆ - 0731-6642300 or Visit https://www.epicresearch.co/

No comments:

Post a Comment